Moderna
MRNA
196.48
+9.02
+4.81%
Moderna
US · MRNA
#406 by market cap
Listed 2018
196.48
+9.02
+4.81%
Live - 5344 symbols - heartbeat 499s ago
· 2026-10-08 07:40
Pre-market
194.92
-0.79%
After-hours
195.47
-0.51%
Overnight
195.45
-0.52%
- Market cap
- 78.44B
- P/E (TTM)i
- -24.62
- P/Bi
- 11.60
- EPSi
- -7.26
- Div yieldi
- 0.00%
- 52W posi
- 92%
Reader sentiment
Are you bullish or bearish on MRNA?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Ownership Signal how this is computed
Distributing
- The number of reporting institutions decreased by 2 in the most recent period (2026/Q3).
- Total institutional ownership fell 2.3 percentage points.
Institutional ownership
- Held by institutions
- 80.52% -2.32pp
- Institutions
- 947 -2
- As of
- 2026/Q3 vs. prior period
Ownership vs. money flow
AlignedInstitutions trimmed shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two line up.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Holder types
Mutual Fund65.06%
Individual/Insider6.69%
Hedge Fund5.31%
Public Company3.59%
Private Company2.44%
VC/PE Fund1.78%
Government Pension Fund0.99%
Sovereign Wealth Fund0.76%
Family Office/Trust0.33%
Other13.04%
Top holders as of 2026-06-30
FMR
12.96% · 51.73M sh
BlackRock
7.66% · 30.60M sh
Vanguard Capital Management, LLC
6.31% · 25.20M sh
Capital Research
5.58% · 22.28M sh
Stéphane Bancel
5.56% · 22.22M sh
Other
61.92%
Baillie Gifford
4.56% · 18.21M sh
State Street Global Advisors
3.94% · 15.73M sh
Vanguard Portfolio Management, LLC
3.90% · 15.58M sh
Geode Capital Management, LLC
2.43% · 9.71M sh
Theleme Partners LLP
2.02% · 8.06M sh
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 22 buys · 27 sells
| Name | Role | Stake |
|---|---|---|
| Stéphane Bancel | Chief Executive Officer | 5.56% |
| Noubar Afeyan | Co-Founder, Independent Non Executive Chairman & Member of Technology Advisory Board | 0.56% |
| Stephen Hoge | President | 0.43% |
| Paul Sagan | Independent Non-Executive Director | 0.08% |
| Shannon Klinger | Chief Legal Officer | 0.02% |
| James Mock | Chief Financial Officer | 0.01% |
| Francois Nader | Independent Non-Executive Director | 0.01% |
| Elizabeth Nabel | Independent Director | 0.00% |
| Sandra Horning | Independent Director | 0.00% |
| Shah Abbas Hussain | Director | 0.00% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-10-04 | Juan Andres | Former President of Strategic Partnerships & Enterprise Expansion | Initial Statement of Beneficial | 0 | -- |
| 2026-09-14 | Stephen Hoge | President | Derivative Exercise and Sale | -80,575 | $12.21–146.07 |
| 2026-09-14 | Stephen Hoge | President | Derivative Exercise and Retained | +72,330 | $12.21 |
| 2026-09-14 | Stephen Hoge | President | Intent to Sell (Form 144) | -40,281 | $146.07 |
| 2026-09-13 | Stephen Hoge | President | Intent to Sell (Form 144) | -40,294 | $144.13 |
| 2026-09-09 | James Mock | Chief Financial Officer | Automatic Disposition | -15,000 | $134.49 |
| 2026-09-09 | James Mock | Chief Financial Officer | Derivative Exercise and Sale | -19,836 | $30.96–134.49 |
| 2026-09-03 | Shannon Klinger | Chief Legal Officer | Derivative Exercise and Sale | -5,704 | $148.87 |
| 2026-09-03 | Shannon Klinger | Chief Legal Officer | Derivative Exercise and Retained | +6,093 | -- |
| 2026-09-03 | James Mock | Chief Financial Officer | Derivative Exercise and Sale | -5,704 | $148.87 |
| 2026-09-03 | James Mock | Chief Financial Officer | Derivative Exercise and Retained | +6,093 | -- |
| 2026-08-31 | Shannon Klinger | Chief Legal Officer | Sale to Issuer | -1,048 | $140.34 |
| 2026-08-31 | Shannon Klinger | Chief Legal Officer | Derivative Exercise and Sale | -3,471 | $30.96–139.95 |
| 2026-08-31 | Shannon Klinger | Chief Legal Officer | Derivative Exercise and Retained | +2,166 | -- |
| 2026-08-31 | Stephen Hoge | President | Derivative Exercise and Sale | -4,489 | $140.34 |
| 2026-08-31 | Stephen Hoge | President | Derivative Exercise and Retained | +4,794 | -- |
| 2026-08-31 | James Mock | Chief Financial Officer | Derivative Exercise and Sale | -1,197 | $140.34 |
| 2026-08-31 | James Mock | Chief Financial Officer | Derivative Exercise and Retained | +1,278 | -- |
| 2026-08-27 | Shannon Klinger | Chief Legal Officer | Derivative Exercise and Sale | -535 | $142.77–149.66 |
| 2026-08-27 | Shannon Klinger | Chief Legal Officer | Derivative Exercise and Retained | +568 | -- |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-10-08 07:40:06 · For reference only, not investment advice and not tailored to your situation.